Video Experimental Relacionado
Updated: Aug 19, 2026

08:52
Generation of Multivirus-specific T Cells to Prevent/treat Viral Infections after Allogeneic Hematopoietic Stem Cell Transplant
Published on: May 27, 2011
Priming de linfocitos T y protección contra la leucemia amistosa por el gen recombinante vaccia-retrovirus env
Resumen
Este estudio creó un recombinante de vacuna-retrovirus para probar la protección inmune contra la leucemia por el virus Friend. El virus modificado protegió con éxito a los ratones contra la leucemia al inducir respuestas inmunes clave.
Área de la Ciencia:
- Inmunología Inmunología.
- Virología Virología.
- Oncología Oncología.
Sus antecedentes:
- La prevalencia del síndrome de inmunodeficiencia adquirida (SIDA) impulsa la investigación sobre la inmunización de las enfermedades retrovirales.
- La comprensión de los mecanismos de protección inmune contra los retrovirus es crucial para el desarrollo de vacunas efectivas.
Objetivo del estudio:
- Construir un vector recombinante vacuna-retrovirus para el estudio de la protección inmune contra la leucemia inducida por el virus Friend.
- Para investigar el papel del gen del sobre en la obtención de inmunidad protectora.
Principales métodos:
- Inserción del gen de la envoltura (env) del virus de la leucemia murina Friend (F-MuLV) en un vector de expresión del virus de la vacuna.
- Inoculación de ratones con el virus de la vacuna recombinante y posterior desafío con el complejo de virus Friend.
- Análisis de las respuestas inmunes, incluida la proliferación de células T, la producción de anticuerpos neutralizantes y la actividad de los linfocitos T citotóxicos (CTL).
Principales resultados:
- Los ratones inoculados con el virus de la vacuna recombinante sintetizaron y procesaron la proteína del sobre F-MuLV (gp85).
- Estos ratones exhibieron una respuesta de células T específicas de la envoltura, desarrollaron anticuerpos neutralizantes y CTL, y fueron protegidos de la leucemia.
- Los grupos de control mostraron una respuesta de anticuerpos retrasada, carecían de CTL y sucumbieron a la leucemia.
Conclusiones:
- El vector recombinante vacuna-retrovirus que expresa el gen F-MuLV env puede inducir inmunidad protectora contra la leucemia por el virus Friend en ratones.
- La inmunidad inducida involucra componentes tanto humoral como celular, incluyendo anticuerpos neutralizantes y CTLs.
- Los principales genes del complejo de histocompatibilidad influyen en la protección mediada por la vacuna recombinante, pero no por el virus Friend atenuado.
Más Videos Relacionados
Videos de Conceptos Relacionados
Vaccinations
Overview
Mechanisms of Retrovirus-induced Cancers
Retroviruses are RNA viruses that have been shown to cause cancers in diverse species, including chickens, mice, cats, and monkeys. The RNA genomes of these viruses are first reverse-transcribed into single and then double-stranded DNA (dsDNA) copies. This dsDNA called proviral DNA then integrates into the host genome. Subsequently, the host cell transcribes the proviral DNA in concert with the chromosomal DNA. This leads to the production of viral RNA and proteins that assemble at the host...
Mechanisms of Retrovirus-induced Cancers
Retroviruses are RNA viruses that have been shown to cause cancers in diverse species, including chickens, mice, cats, and monkeys. The RNA genomes of these viruses are first reverse-transcribed into single and then double-stranded DNA (dsDNA) copies. This dsDNA called proviral DNA then integrates into the host genome. Subsequently, the host cell transcribes the proviral DNA in concert with the chromosomal DNA. This leads to the production of viral RNA and proteins that assemble at the host...
Immune Response Against Viral Pathogens
The immune system's response to viral infections is a complex and coordinated process involving natural killer (NK) cells, T cell-mediated responses, and antibody-mediated responses.
NK Cells
NK cells are a crucial part of our innate immune system, acting as the first line of defense against viral infections. These cells can recognize and kill infected cells without prior exposure to the virus, effectively slowing down the spread of infection. Additionally, NK cells produce proinflammatory...
NK Cells
NK cells are a crucial part of our innate immune system, acting as the first line of defense against viral infections. These cells can recognize and kill infected cells without prior exposure to the virus, effectively slowing down the spread of infection. Additionally, NK cells produce proinflammatory...
Cancer Vaccines
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Vaccines
Vaccines are among the most effective tools in preventive medicine, designed to prepare the immune system to recognize and combat infectious agents. By introducing antigens—substances that the immune system identifies as foreign—vaccines stimulate an adaptive immune response that leads to immunological memory. This immunological memory enables the body to mount a faster and more effective response upon future exposures to the actual pathogen.Vaccines can be categorized based on the type of...

